Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association.

Published

Journal Article (Review)

Cardiovascular disease risk factor control as primary prevention in patients with type 2 diabetes mellitus has changed substantially in the past few years. The purpose of this scientific statement is to review the current literature and key clinical trials pertaining to blood pressure and blood glucose control, cholesterol management, aspirin therapy, and lifestyle modification. We present a synthesis of the recent literature, new guidelines, and clinical targets, including screening for kidney and subclinical cardiovascular disease for the contemporary management of patients with type 2 diabetes mellitus.

Full Text

Cited Authors

  • Fox, CS; Golden, SH; Anderson, C; Bray, GA; Burke, LE; de Boer, IH; Deedwania, P; Eckel, RH; Ershow, AG; Fradkin, J; Inzucchi, SE; Kosiborod, M; Nelson, RG; Patel, MJ; Pignone, M; Quinn, L; Schauer, PR; Selvin, E; Vafiadis, DK; American Heart Association Diabetes Committee of the Council on Lifestyle and Cardiometabolic Health, Council on Clinical Cardiology, Council on Cardiovascular and Stroke Nursing, Council on Cardiovascular Surgery and Anesthesia, Council on Quality of Care and Outcomes Research, and the American Diabetes Association,

Published Date

  • August 5, 2015

Published In

Volume / Issue

  • 132 / 8

Start / End Page

  • 691 - 718

PubMed ID

  • 26246173

Pubmed Central ID

  • 26246173

Electronic International Standard Serial Number (EISSN)

  • 1524-4539

International Standard Serial Number (ISSN)

  • 0009-7322

Digital Object Identifier (DOI)

  • 10.1161/cir.0000000000000230

Language

  • eng